Literature DB >> 25559687

Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.

Jean-Michel Lemée1, Anne Clavreul, Marc Aubry, Emmanuelle Com, Marie de Tayrac, Pierre-Antoine Eliat, Cécile Henry, Audrey Rousseau, Jean Mosser, Philippe Menei.   

Abstract

Glioblastoma (GB) is the most frequent and aggressive type of primary brain tumor. Recurrences are mostly located at the margin of the resection cavity in the peritumoral brain zone (PBZ). Although it is widely believed that infiltrative tumor cells in this zone are responsible for GB recurrence, few studies have examined this zone. In this study, we analyzed PBZ left after surgery with a variety of techniques including radiology, histopathology, flow cytometry, genomic, transcriptomic, proteomic, and primary cell cultures. The resulting PBZ profiles were compared with those of the GB tumor zone and normal brain samples to identify characteristics specific to the PBZ. We found that tumor cell infiltration detected by standard histological analysis was present in almost one third of PBZ taken from an area that was considered normal both on standard MRI and by the neurosurgeon under an operating microscope. The panel of techniques used in this study show that the PBZ, similar to the tumor zone itself, is characterized by substantial inter-patient heterogeneity, which makes it difficult to identify representative markers. Nevertheless, we identified specific alterations in the PBZ such as the presence of selected tumor clones and stromal cells with tumorigenic and angiogenic properties. The study of GB-PBZ is a growing field of interest and this region needs to be characterized further. This will facilitate the development of new, targeted therapies for patients with GB and the development of approaches to refine the per-operative evaluation of the PBZ to optimize the surgical resection of the tumor.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25559687     DOI: 10.1007/s11060-014-1695-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  38 in total

1.  Morphological and flow cytometric analysis of cell infiltration in glioblastoma: a comparison of autopsy brain and neuroimaging.

Authors:  Takahiro Yamahara; Yoshihiro Numa; Tetsuya Oishi; Takuya Kawaguchi; Toshitaka Seno; Akio Asai; Keiji Kawamoto
Journal:  Brain Tumor Pathol       Date:  2010-11-03       Impact factor: 3.298

2.  The significance of biochemical and molecular sample integrity in brain proteomics and peptidomics: stathmin 2-20 and peptides as sample quality indicators.

Authors:  Karl Sköld; Marcus Svensson; Mathias Norrman; Benita Sjögren; Per Svenningsson; Per E Andrén
Journal:  Proteomics       Date:  2007-12       Impact factor: 3.984

3.  Graphic analysis of microscopic tumor cell infiltration, proliferative potential, and vascular endothelial growth factor expression in an autopsy brain with glioblastoma.

Authors:  G Nagashima; R Suzuki; H Hokaku; M Takahashi; T Miyo; J Asai; N Nakagawa; T Fujimoto
Journal:  Surg Neurol       Date:  1999-03

4.  A 4-gene signature associated with clinical outcome in high-grade gliomas.

Authors:  Marie de Tayrac; Marc Aubry; Stephan Saïkali; Amandine Etcheverry; Cyrille Surbled; Frédérique Guénot; Marie-Dominique Galibert; Abderrahmane Hamlat; Thierry Lesimple; Véronique Quillien; Philippe Menei; Jean Mosser
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

5.  Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Authors:  Andrés Server; Bettina Kulle; Øystein B Gadmar; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Eur J Radiol       Date:  2010-08-13       Impact factor: 3.528

6.  Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.

Authors:  A Server; B Kulle; J Maehlen; R Josefsen; T Schellhorn; T Kumar; C W Langberg; P H Nakstad
Journal:  Acta Radiol       Date:  2009-07       Impact factor: 1.990

7.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.

Authors:  Roger Stupp; Monika E Hegi; Warren P Mason; Martin J van den Bent; Martin J B Taphoorn; Robert C Janzer; Samuel K Ludwin; Anouk Allgeier; Barbara Fisher; Karl Belanger; Peter Hau; Alba A Brandes; Johanna Gijtenbeek; Christine Marosi; Charles J Vecht; Karima Mokhtari; Pieter Wesseling; Salvador Villa; Elizabeth Eisenhauer; Thierry Gorlia; Michael Weller; Denis Lacombe; J Gregory Cairncross; René-Olivier Mirimanoff
Journal:  Lancet Oncol       Date:  2009-03-09       Impact factor: 41.316

8.  Independent association of extent of resection with survival in patients with malignant brain astrocytoma.

Authors:  Matthew J McGirt; Kaisorn L Chaichana; Muraya Gathinji; Frank J Attenello; Khoi Than; Alessandro Olivi; Jon D Weingart; Henry Brem; Alf Redo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2009-01       Impact factor: 5.115

Review 9.  Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.

Authors:  Michael J Colditz; Rosalind L Jeffree
Journal:  J Clin Neurosci       Date:  2012-09-05       Impact factor: 1.961

10.  DNA methylation in glioblastoma: impact on gene expression and clinical outcome.

Authors:  Amandine Etcheverry; Marc Aubry; Marie de Tayrac; Elodie Vauleon; Rachel Boniface; Frederique Guenot; Stephan Saikali; Abderrahmane Hamlat; Laurent Riffaud; Philippe Menei; Veronique Quillien; Jean Mosser
Journal:  BMC Genomics       Date:  2010-12-14       Impact factor: 3.969

View more
  20 in total

1.  Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.

Authors:  Hao Yu; Huiling Lou; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Zhongqing Huang; Yongxing Du; Chunxiu Jiang; Ling Ma; Jianbin Zhu; Wen He; Qihong Rui; Jianyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

2.  Radiomic features from the peritumoral brain parenchyma on treatment-naïve multi-parametric MR imaging predict long versus short-term survival in glioblastoma multiforme: Preliminary findings.

Authors:  Prateek Prasanna; Jay Patel; Sasan Partovi; Anant Madabhushi; Pallavi Tiwari
Journal:  Eur Radiol       Date:  2016-10-24       Impact factor: 5.315

3.  Simulating vasogenic brain edema using chronic VEGF infusion.

Authors:  Martin Piazza; Jeeva Munasinghe; Roger Murayi; Nancy Edwards; Blake Montgomery; Stuart Walbridge; Marsha Merrill; Prashant Chittiboina
Journal:  J Neurosurg       Date:  2017-01-06       Impact factor: 5.115

Review 4.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.

Authors:  Jean-Michel Lemée; Anne Clavreul; Philippe Menei
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

5.  Quantitative MRI for analysis of peritumoral edema in malignant gliomas.

Authors:  Ida Blystad; J B Marcel Warntjes; Örjan Smedby; Peter Lundberg; Elna-Marie Larsson; Anders Tisell
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

6.  Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link.

Authors:  Jean-Michel Lemée; Anne Clavreul; Marc Aubry; Emmanuelle Com; Marie de Tayrac; Jean Mosser; Philippe Menei
Journal:  BMC Mol Biol       Date:  2018-11-21       Impact factor: 2.946

7.  Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement.

Authors:  Jiun-Lin Yan; Chao Li; Natalie R Boonzaier; Daniel M Fountain; Timothy J Larkin; Tomasz Matys; Anouk van der Hoorn; Stephen J Price
Journal:  Ther Adv Neurol Disord       Date:  2019-05-14       Impact factor: 6.570

8.  The French glioblastoma biobank (FGB): a national clinicobiological database.

Authors:  Anne Clavreul; Gwénaëlle Soulard; Jean-Michel Lemée; Marion Rigot; Pascale Fabbro-Peray; Luc Bauchet; Dominique Figarella-Branger; Philippe Menei
Journal:  J Transl Med       Date:  2019-04-23       Impact factor: 5.531

9.  The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma.

Authors:  Enrico Brognaro
Journal:  Clin Transl Oncol       Date:  2021-06-21       Impact factor: 3.405

Review 10.  A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.

Authors:  John Trusheim; Erin Dunbar; James Battiste; Fabio Iwamoto; Nimish Mohile; Denise Damek; Daniela A Bota; Jennifer Connelly
Journal:  CNS Oncol       Date:  2016-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.